Immunome had a revenue of 2.93M in the quarter ending Mar 31, 2025, with 6.87%. This bring the company's revenue in the last twelve months to 10.94M, Decreased 20.98%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.